[go: up one dir, main page]

WO2008039351A3 - Method of manufacturing tablets containing pharmacologically active agents - Google Patents

Method of manufacturing tablets containing pharmacologically active agents Download PDF

Info

Publication number
WO2008039351A3
WO2008039351A3 PCT/US2007/020406 US2007020406W WO2008039351A3 WO 2008039351 A3 WO2008039351 A3 WO 2008039351A3 US 2007020406 W US2007020406 W US 2007020406W WO 2008039351 A3 WO2008039351 A3 WO 2008039351A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmacologically active
active agents
tablets containing
containing pharmacologically
manufacturing tablets
Prior art date
Application number
PCT/US2007/020406
Other languages
French (fr)
Other versions
WO2008039351A2 (en
Inventor
Anasuya Ashok Ghosh
Yatindra Joshi
Shoufeng Li
Alan Edward Royce
Colleen Ruegger
Original Assignee
Novartis Ag
Anasuya Ashok Ghosh
Yatindra Joshi
Shoufeng Li
Alan Edward Royce
Colleen Ruegger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Anasuya Ashok Ghosh, Yatindra Joshi, Shoufeng Li, Alan Edward Royce, Colleen Ruegger filed Critical Novartis Ag
Publication of WO2008039351A2 publication Critical patent/WO2008039351A2/en
Publication of WO2008039351A3 publication Critical patent/WO2008039351A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A method of improving the physical properties of an solid oral dosage form, especially a tablet, uses an external lubricant during the compaction process. The solid oral dosage form comprises a pharmacologically active agent, for example a protein or polypeptide, and a delivery agent. Tablet properties, such as hardness, disintegration time and dissolution, are improved using the method.
PCT/US2007/020406 2006-09-22 2007-09-20 Method of manufacturing tablets containing pharmacologically active agents WO2008039351A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82659706P 2006-09-22 2006-09-22
US60/826,597 2006-09-22

Publications (2)

Publication Number Publication Date
WO2008039351A2 WO2008039351A2 (en) 2008-04-03
WO2008039351A3 true WO2008039351A3 (en) 2008-06-19

Family

ID=39227036

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/020406 WO2008039351A2 (en) 2006-09-22 2007-09-20 Method of manufacturing tablets containing pharmacologically active agents

Country Status (5)

Country Link
AR (1) AR062925A1 (en)
CL (1) CL2007002724A1 (en)
PE (1) PE20080845A1 (en)
TW (1) TW200820993A (en)
WO (1) WO2008039351A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS56998B1 (en) 2010-12-16 2018-05-31 Novo Nordisk As Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid
CA2832811A1 (en) 2011-04-12 2012-10-18 Novo Nordisk A/S Double-acylated glp-1 derivatives
HUE062740T2 (en) 2012-03-22 2023-12-28 Novo Nordisk As Preparations of GLP-1 peptides and their production
WO2013139695A1 (en) 2012-03-22 2013-09-26 Novo Nordisk A/S Compositions comprising a delivery agent and preparation thereof
HUE042757T2 (en) 2012-03-22 2019-07-29 Novo Nordisk As Compositions comprising a delivery agent and preparation thereof
EP2863895B1 (en) 2012-06-20 2021-04-14 Novo Nordisk A/S Tablet formulation comprising a peptide and a delivery agent
MX369259B (en) 2013-05-02 2019-11-04 Novo Nordisk As ORAL DOSAGE OF PEPTIDE COMPOUNDS SIMILAR TO GLAUCON-1 (GLP-1).
HUE063787T2 (en) 2018-02-02 2024-01-28 Novo Nordisk As Solid preparations containing a GLP-1 agonist, an N-(8-(2-hydroxybenzoyl)amino) caprylic acid salt and a lubricant

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1070496A1 (en) * 1998-04-08 2001-01-24 Kyowa Hakko Kogyo Co., Ltd. Tablet manufacturing method and tablet
WO2005004900A1 (en) * 2003-07-11 2005-01-20 Novartis Ag Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1070496A1 (en) * 1998-04-08 2001-01-24 Kyowa Hakko Kogyo Co., Ltd. Tablet manufacturing method and tablet
WO2005004900A1 (en) * 2003-07-11 2005-01-20 Novartis Ag Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ARTHUR H. KIBBE: "Handbook of PHARMACEUTICAL EXCIPIENTS", 2000, AMERICAN PHARMACEUTICAL ASSOCIATION AND THE PHARMACEUTICAL PRESS, USA, XP002475352 *

Also Published As

Publication number Publication date
CL2007002724A1 (en) 2008-05-16
TW200820993A (en) 2008-05-16
WO2008039351A2 (en) 2008-04-03
PE20080845A1 (en) 2008-08-13
AR062925A1 (en) 2008-12-17

Similar Documents

Publication Publication Date Title
WO2008039351A3 (en) Method of manufacturing tablets containing pharmacologically active agents
WO2006117228A3 (en) Ophthalmic devices for sustained delivery of active compounds
MY147641A (en) Fast release paracetamol tablets
WO2008017867A3 (en) Antiretroviral solid oral composition with at least one water insoluble polymer
AP2006003521A0 (en) Y-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it.
WO2010066749A3 (en) Ulipristal acetate tablets
WO2008124617A3 (en) Rapidly dissolving pharmaceutical compositions comprising pullulan
AU2007211091A8 (en) Drug delivery systems comprising weakly basic selective serotonin 5-HT3 blocking agent and organic acids
MY161079A (en) Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic
RS50812B (en) Dry granulated composition comprising emtricitabine and tenofovir df
UA93353C2 (en) Manufacturing of quick release pharmaceutical compositions of water insoluble drugs and pharmaceutical compositions prepared by the process of the invention
WO2009111611A3 (en) Compounds, compositions and methods for the treatment of islet amyloid polypeptide (iapp) accumulation in diabetes
FI20080548A7 (en) Orodispersible tablets containing escitalopram base and method for their preparation
WO2007021968A3 (en) Sustained release antihistamine and decongestant composition
WO2003026610A3 (en) Process for the preparation of fast dissolving dosage form
PL1651248T3 (en) Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form
WO2008101173A3 (en) Biodegradable compositions and materials
GB2446341A (en) Method and system for transdermal drug delivery
WO2007016350A3 (en) Modified release tablet formulations with enhanced mechanical properties
WO2008079343A3 (en) Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients
WO2007007182A3 (en) Solid and liquid dosage forms of an antiepileptic agent
IL179177A (en) Pharmaceutical composition comprising acyclovir and a delivery agent, a dosage unit, use of acyclovir in the preparation of the pharmaceutical composition, use of the pharmaceutical composition in the preparation of a medicament and a method of preparing the pharmaceutical composition
WO2007120838A3 (en) Rapidly disintegrating solid oral dosage form of liquid dispersions
MX2009007057A (en) Duloxetine composition.
WO2009135949A3 (en) Process for preparing a very high drug load tablet

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07861347

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07861347

Country of ref document: EP

Kind code of ref document: A2